RBC U.S. Mid-Cap Growth Equity Fund Series F (RBF617)

RBC U.S. Mid-Cap Growth Equity Fund Series F (RBF617 $66.30)
- $66.30 P/E (TTM): 25.6X
- View RBF617 Profile
- View Questions on RBF617

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

RBC U.S. Mid-Cap Growth Equity Fund Series F (RBF617 $66.30)
- $66.30 P/E (TTM): 25.6X
- View RBF617 Profile
- View Questions on RBF617
NuScale Power Corporation Class A (SMR $19.04)
- $19.04 Cap: $5.76B
- View SMR Profile
- View Questions on SMR
AtkinsRéalis Group Inc. (ATRL $86.66)
- $86.66 P/E (TTM): 5.97X Cap: $14.36B
- View ATRL Profile
- View Questions on ATRL

Q: Ok, let's try this again.

For the past 2+ years I've been waiting for the RBC US Midcap Fund to pop.

So a "gut" response to my first question: given the recent sell off in the markets, do you see small/midcaps popping or continuing to languish in the shadows of the AI trade? (Although it's early, in terms of seasonality the fund is doing nothing).

Second question: I'm thinking of taking all or half of this position (it's a full position for me), and picking up ATRL based on the nuclear energy/SMR theme. ATRL is up significantly in the past year. Is it fully priced at this point or does it have a lot more to grow in the next five years? Considering the the nuclear/SMR theme, would it be your top pick or do you have other companies (Canada or US) that you favour more?

Thanks in advance,
Pete, Calgary

Read Answer Asked by Peter on November 17, 2025

RBC U.S. Mid-Cap Growth Equity Fund Series F (RBF617 $66.30)
- $66.30 P/E (TTM): 25.6X
- View RBF617 Profile
- View Questions on RBF617
BMO S&P US Mid Cap Index ETF (ZMID $49.98)
- $49.98 P/E (TTM): 20.39X Cap: $284M
- View ZMID Profile
- View Questions on ZMID

Q: Could you please give your opinion on ZMID and RBF617 - which would you prefer over the next 5 years. Also, with the Canadian / US $ exchange rate currently being where it is, would this be a good time to use the hedged version of the above or do you prefer the unhedged versions?

Thank you so much!!

Read Answer Asked by Barbara on December 10, 2024